This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CVS Caremark Recognizes The Important Role Pharmacists Play In Improving Health Outcomes For Their Patients

Stocks in this article: CVS

WOONSOCKET, R.I., Oct. 3, 2013 /PRNewswire/ -- In recognition of American Pharmacists Month in October, CVS Caremark is thanking its pharmacists for their role in reinventing pharmacy to help people on their path to better health. CVS Caremark's 26,000 pharmacists are improving patient care and lowering health care costs every day in the company's retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

"CVS Caremark is focused on finding new and innovative ways to reinvent pharmacy in order to better serve our customers and our pharmacists play a critical role in that process," said Larry Merlo, President and CEO of CVS Caremark. "The health care landscape in our nation is changing and pharmacists are no longer simply dispensing medication. Our pharmacists are also providing important health care services through innovative programs and services across our practice settings."

  • CVS Caremark pharmacists are creating convenient and affordable access to health care through flu vaccinations and other immunizations in all 7,500 CVS/pharmacy locations.
  • They are also playing a critical role at CVS Caremark's new state of the art mail service pharmacy and customer center in Illinois, which combines the best of high tech automation and human expertise to provide convenient, affordable access to prescriptions.
  • As new health insurance coverage options are made available under the Affordable Care Act, CVS pharmacists will serve as a point of activation for patients who are seeking information about their options under the new health care law.  
  • Pharmacists are the lynchpin in CVS Caremark's Pharmacy Advisor program, unique to the Company's integrated model, that addresses issues of non-adherence and identifies gaps in care to improve the health of people with chronic diseases through pharmacist consultations.

On October 22, 2013, CVS Caremark will also celebrate National Pharmacy Technician Day in recognition of the valuable role that its 50,000 pharmacy technicians play in supporting CVS Caremark pharmacists and the pivotal role they play in the company's many pharmacies.

About CVS CaremarkCVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,500 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 650 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases, such as diabetes, obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

Contact:

Mike DeAngelisCorporate Communications(401) 770-2645  Michael.DeAngelis@cvscaremark.com

Amy LanctotCorporate Communications(401) 770-2931 Amy.Lanctot@cvscaremark.com

SOURCE CVS Caremark

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,326.98 -89.87 -0.52%
S&P 500 2,015.57 -5.68 -0.28%
NASDAQ 4,681.6570 -1.75 -0.04%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs